Evidence map›Paper›PMID 37868550›Full record

ReviewCureus2023

Advancements in Myocardial Infarction Management: Exploring Novel Approaches and Strategies.

Pranav Sachdeva, Kawanpreet Kaur, Saba Fatima, Fnu Mahak, Muhammad Noman, Sowmya Manjari Siddenthi, Marvi Alais Surksha, Mishaal Munir, Fnu Fatima, Syeda Salima Sultana and 5 more

Abstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Circulating-free DNA: A promising tool for early detection of myocardial infarction.International journal of cardiology. Cardiovascular risk and prevention · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Pranav SachdevaGeneral Medicine, Government Medical College & Hospital, Chandigarh, Chandigarh, IND.
Kawanpreet KaurGeneral Medicine, Government Medical College & Hospital, Chandigarh, Chandigarh, IND.
Saba FatimaMedicine, Jinnah Sindh Medical University, Karachi, PAK.
Fnu MahakMedicine, Jinnah Postgraduate Medical Centre, Karachi, PAK.
Muhammad NomanInternal Medicine, Ziauddin University, Karachi, PAK.
Sowmya Manjari SiddenthiInternal Medicine, Osmania Medical College, Hyderabad, IND.
Marvi Alais SurkshaMedicine, Ghulam Muhammad Mahar Medical College, Sukkur, PAK.
Mishaal MunirMedicine, Ghurki Trust and Teaching Hospital, Lahore, PAK.
Fnu FatimaMedicine, Jinnah Sindh Medical University, Karachi, PAK.
Syeda Salima SultanaMedicine, Southern Medical College and Hospital, Chittagong, BGD.
Giustino VarrassiPain Medicine, Paolo Procacci Foundation, Rome, ITA.
Mahima KhatriMedicine and Surgery, Dow University of Health Sciences, Karachi, Karachi, PAK.
Satesh KumarMedicine and Surgery, Shaheed Mohtarma Benazir Bhutto Medical College, Karachi, PAK.
Mahir ElderInterventional Cardiology, Heart and Vascular Institute, Detroit, USA.
Tamam MohamadCardiovascular Surgery, Wayne State University, Detroit, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the landscape of healthcare, the management of myocardial infarction (MI) stands as a pivotal challenge and a critical juncture where advancements are reshaping the trajectory of patient care. Myocardial infarction, commonly known as a heart attack, remains a foremost contributor to global morbidity and mortality. Conventional management strategies have historically focused on rapid restoration of blood flow through revascularization techniques. However, the last decade has witnessed a profound transformation, with a burgeoning emphasis on precision medicine and innovative interventions. This contextual backdrop sets the stage for a deep dive into the realm of novel diagnostic modalities, spanning high-sensitivity biomarkers, advanced imaging techniques, and data-driven algorithms. These innovations facilitate not only early detection but also the stratification of patients, paving the way for individualized treatment plans. By targeting the underlying mechanisms of myocardial damage, these interventions hold the promise of attenuating the impact of MI and promoting cardiac regeneration. It examines the integration of telemedicine, wearable devices, and remote monitoring platforms, bridging the gap between patients and caregivers while enabling timely interventions. Additionally, the psychosocial aspects of MI recovery are explored, highlighting the integration of psychological support and lifestyle interventions to enhance long-term well-being. By exploring novel diagnostics, innovative therapies, and holistic patient-centered strategies, it underscores the collaborative efforts of medical practitioners, researchers, and technological pioneers in reshaping the trajectory of MI care. As we stand at the intersection of medical advancement and compassionate patient management, embracing these novel approaches promises a future where the impact of myocardial infarction can be mitigated, and lives can be extended and enriched.

Indexed as

advancements managementcardiac caremyocardial infarctionnovel approachesstrategies

Identifiers

PMID37868550
PMCPMC10587445

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.